Dr. Mark Kiel, Founder and Chief Scientific Officer of Genomenon based in the United States participate in Risk Roundup to discuss Diagnostic Genomics and Security Risks – Genomic Search Engines and Genome Interpretation. Genomics Diagnostics and Security Risks How is Human Disease Genomics transforming medicine? It is said that this is the best of times for Human Disease Genomics. In the coming years, due to advances in technology, massive genomic data sets from human patients and controls will likely be created and stored. Along with the advanced mechanisms for the creation, storage, analysis, integration, and interpretation of a wide variety of genomic data types, Medicine and Healthcare will likely go through fundamental transformation and revolution. As a result, we will see continued growth in the number of disease genes identified. In addition, we will also develop a deepening of our understanding of the fundamental genetic architecture and human disease states. So, what will be its impact? What will be the meaning of human disease genomic data?What would be required to understand and evaluate massive genomic data? It seems that because of the massive increase in genomic data creation and availability, the race to build a search engine for Human DNA is on its way. It is important that we evaluate the strategic impact and complex security risks that emerge with the availability of massive human genomic data and the accessibility that Genomic Search Engines provides. Genomics Diagnostics and Security Risks As genome companies are trying to be the search engine for personalized medicine, it is important to evaluate its impact and strategic security risks. Time is now to talk about Genomic Medicine, Personalized Medicine, Genomic Search Engines, and Security Risks! For more please watch the Risk Roundup Webcast or hear the Risk Roundup Podcast About the Guest Dr. Mark Kiel MD, PPh.D. is the Founder and CSO of Genomenon. He practiced as a molecular pathologist at The University of Michigan and has extensive experience in genomic analysis and the clinical application of genomics. Dr. Kiel completed his medical residency in Clinical Pathology in 2014 and a fellowship in Molecular Genetic Pathology in 2015 at the University of Michigan before starting Genomenon. He has an exemplary record of scientific research including publications in Cell, Science, and Nature for which he has won numerous international awards. He has extensive experience in genome sequence analysis and has first-hand knowledge of the clinical use of these data. He envisioned the technology underlying the Genomenon suite of software tools. Dr. Kiel has extensive experience in genome-sequence data analysis and first-hand knowledge of the clinical use of these data. He serves in an advisory position to a number of research investigators and clinical diagnosticians nationwide and devised the technology underlying the Genomenon suite of software tools. About Risk Group Risk Group is a leading strategic security risk research and advisory organization. Copyright Risk Group LLC. All Rights Reserved Reference Episodes Future of Work – Battle between Human Work Force and Machine Work ForceTechnology Trends and Future of HumanityTechnology Trends and HumanificationDual Use Technology Dilemma and National Security RisksElectronic Warfare PreparednessFuture of TechnologyDigital Future – Complex Challenges of ChangeElectronic Warfare-An Existential RiskElectromagnetic WarfareWhat Role Gene Environment Plays In Gene Expression And Human Health SecurityFourth Industrial Revolution and SecurityMachine Learning Bias – An Existential RiskRisks and Rewards of Genomic MedicineCompetitive Intelligence and Risk ManagementStrategic IntelligenceDisruptive Innovation and Security RisksNanoSatellites & Democratization of SpaceHealthcare in TurmoilSpace MiningSpace SecurityImpact InvestingBioEconomy – Promise and Perils of Synthetic BiologySocietal Impact of RoboticsComplex Security Risks of Mediterranean RegionAre Education Institutions Prepared for Digital DisruptionDigital Disruption in MarketingThe Middle East Geopolitical Puzzle and Risks to Global SecurityImpact of Cyber-Security Risks Global BusinessThe Digital Global Age – Contested CommonsStrategizing Digital TransformationStrategizing Cyber-SecurityEnergy Warfare The post Diagnostic Genomics and Security Risks appeared first on Risk Group.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related